1. Home
  2. TMC vs FATE Comparison

TMC vs FATE Comparison

Compare TMC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TMC the metals company Inc.

TMC

TMC the metals company Inc.

HOLD

Current Price

$7.42

Market Cap

2.9B

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

131.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMC
FATE
Founded
2011
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
131.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TMC
FATE
Price
$7.42
$1.11
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$6.94
$3.92
AVG Volume (30 Days)
9.5M
1.2M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.66
52 Week High
$11.35
$2.31

Technical Indicators

Market Signals
Indicator
TMC
FATE
Relative Strength Index (RSI) 56.98 50.19
Support Level $6.26 $1.03
Resistance Level $8.14 $1.16
Average True Range (ATR) 0.59 0.07
MACD 0.17 0.01
Stochastic Oscillator 77.23 76.30

Price Performance

Historical Comparison
TMC
FATE

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: